GUS: Gadavist Drug Utilization Study
Latest Information Update: 04 Apr 2024
At a glance
- Drugs Gadobutrol (Primary)
- Indications Breast cancer; Coronary artery disease; Vascular disorders
- Focus Diagnostic use
- Acronyms GUS
- Sponsors Bayer
Most Recent Events
- 09 May 2023 Status changed from active, no longer recruiting to completed.
- 06 Apr 2023 Status changed from recruiting to active, no longer recruiting.
- 10 Feb 2023 Planned End Date changed from 26 May 2023 to 27 Apr 2023.